// Auto-generated - do not edit
export const substanceName = "JWH-073";
export const sources = [{"id":"drugusersbible","fileName":"DRUGUSERSBIBLE - JWH-073.md","displayName":"Drug Users Bible","size":1372},{"id":"protestkit","fileName":"PROTESTKIT - JWH-073.json","displayName":"Protest Kit","size":2719},{"id":"wikipedia","fileName":"WIKIPEDIA - JWH-073.md","displayName":"Wikipedia","size":3278}];
export const contents: Record<string, string> = {
  "drugusersbible": `# JWH-073
*Source: Drug Users Bible by Dominic Milton Trott*

*Section 2.8.5 - CHEMSCAPE: A Chemical Journey*

## Quick Reference
- **Common Nomenclature:** JWH- 073
- **Street & Reference Names:** Spice
- **Reference Dosage:** Light 3mg+; Common 5mg+; Strong^ 10mg+;
- **Anticipated: Onset / Duration:** 30 Seconds / 2 Hours
- **Maximum Dose Experienced:** Unknown
- **Form:** Smoking Mixture
- **RoA:** Smoked
- **Source / Jurisdiction:** Head Shop / UK

## Subjective Experience

This was launched under the authentic Spice brand, and as far as I can recall, was the
first variation from JWH-018 in the original series. As a novice, the difference
between them was difficult to establish.

Again, certain elements of the experience were cannabis-like, but only to a limited
extent. Some aspects were absent, and others were somewhat distorted. However, at
the time it offered a decent enough experience to repeatedly engage.

On the face of it, this chemical seemed to have a similar safety profile to its earlier
cousin. Given what was eventually to emerge in terms of synthetic cannabinoids, this
was probably a positive.

The spice brand itself disappeared not far down the track, before most of the stronger
cannabinoids became available under a huge variety of different labels and names.
Its legacy, however, including the misappropriation of its name, remained.
`,
  "protestkit": `{
  "url": "https://en.wikipedia.org/wiki/JWH-073_(Spice)",
  "experiencesUrl": "https://www.reddit.com/search/?q=JWH-073+(Spice)",
  "name": "JWH-073 (Spice)",
  "aliases": [],
  "aliasesStr": "",
  "summary": "This is an obscure substance with no entry in PsychoanutWiki or TripSit. Reliable data is unavailable.",
  "reagents": null,
  "classes": {
    "chemical": [
      "Cannabinoid"
    ]
  },
  "toxicity": null,
  "addictionPotential": null,
  "tolerance": null,
  "crossTolerances": null,
  "roas": [],
  "interactions": [
    {
      "name": "2C-T-x",
      "status": "Caution"
    },
    {
      "name": "2C-x",
      "status": "Caution"
    },
    {
      "name": "5-MeO-xxT",
      "status": "Caution"
    },
    {
      "name": "Alcohol",
      "status": "Low Risk & Synergy"
    },
    {
      "name": "Amphetamines",
      "status": "Caution"
    },
    {
      "name": "Benzos",
      "status": "Low Risk & Decrease"
    },
    {
      "name": "Caffeine",
      "status": "Low Risk & No Synergy"
    },
    {
      "name": "Cocaine",
      "status": "Caution"
    },
    {
      "name": "DMT",
      "status": "Caution"
    },
    {
      "name": "DOx",
      "status": "Caution"
    },
    {
      "name": "DXM",
      "status": "Low Risk & Synergy"
    },
    {
      "name": "GHB/GBL",
      "status": "Low Risk & Synergy"
    },
    {
      "name": "Gabapentinoids",
      "status": "Unsafe"
    },
    {
      "name": "Ketamine",
      "status": "Low Risk & Synergy"
    },
    {
      "name": "LSD",
      "status": "Caution"
    },
    {
      "name": "MAOIs",
      "status": "Low Risk & Synergy"
    },
    {
      "name": "MDMA",
      "status": "Low Risk & Synergy"
    },
    {
      "name": "MMC class",
      "status": "Low Risk & Synergy"
    },
    {
      "name": "MXE",
      "status": "Low Risk & Synergy"
    },
    {
      "name": "Mescaline",
      "status": "Caution"
    },
    {
      "name": "Mushrooms",
      "status": "Caution"
    },
    {
      "name": "NBOMes",
      "status": "Caution"
    },
    {
      "name": "Nitrous",
      "status": "Low Risk & Synergy"
    },
    {
      "name": "Opioids",
      "status": "Low Risk & Synergy"
    },
    {
      "name": "PDA5",
      "status": "Low Risk & No Synergy"
    },
    {
      "name": "PVP class",
      "status": "Caution"
    },
    {
      "name": "Poppers",
      "status": "Unsafe"
    },
    {
      "name": "SSRIs",
      "status": "Low Risk & No Synergy"
    },
    {
      "name": "Tramadol",
      "status": "Low Risk & Synergy"
    }
  ],
  "effects": null,
  "categorized_effects": {
    "Physical effects": [],
    "Mental effects": [],
    "Sensory effects": [],
    "Uncategorized effects": []
  }
}`,
  "wikipedia": `# JWH-073
*Source: https://en.wikipedia.org/wiki/JWH-073*

JWH-073, a synthetic cannabinoid, is an analgesic chemical from the naphthoylindole family that acts as a full agonist at both the CB1 and CB2 cannabinoid receptors. It is somewhat selective for the CB1 subtype, with affinity at this subtype approximately 5Ã— the affinity at CB2. The abbreviation JWH stands for John W. Huffman, one of the inventors of the compound.
On 20 April 2009, JWH-073 was claimed by researchers at the University of Freiburg to have been found in a "fertiliser" product called "Forest Humus", along with another synthetic cannabinoid (C8)-CP 47,497. These claims were confirmed in July 2009 when tests of Spice product, seized after the legal ban on JWH-018 had gone into effect in Germany, were shown to contain the unregulated compound JWH-073 instead.
Analgesic effects of cannabinoid ligands have been demonstrated in multiple animal pain models (neuropathic, nociceptive).
These compounds work by mimicking the body's naturally-produced endocannabinoid hormones such as 2-arachidonoylglycerol and anandamide, which are biologically active and can exacerbate or inhibit nerve signaling.

## Pharmacology

JWH-073 has been shown to produce behavioral effects very similar to THC in animals.
Its effects are produced by binding and acting as an agonist to the CB1 and CB2 cannabinoid receptors. The CB1 receptor is found in the brain. JWH-073 binds to CB1 with a higher affinity than THC.  CB2 is found outside the brain, mostly in the immune system. The binding with CB2 receptors has been shown to be similar between JWH-073 and THC.
A search in the literature yielded no published studies of the effects of JWH-073 in humans, but these studies in animals suggest with high probability that JWH-073 produces effects very similar to those of THC in humans.

## Derivatives

The 4'-methyl derivative of JWH-073 has been encountered as an ingredient of synthetic cannabis blends in Germany and several other European countries since 2010. The 4'-methoxy derivative JWH-080 is also known to be a potent cannabinoid agonist and has been banned in some countries, though it is unclear if it has also been used in synthetic cannabis smoking blends.

## Legal status

### United States

The US DEA temporarily declared JWH-073 a schedule I controlled substance on 1 March 2011 through 76 FR 11075, and permanently instated the same schedule on 9 July 2012 in the Section 1152 of the Food and Drug Administration Safety and Innovation Act.

### Australia

On 8 July 2011 the AUS government banned the sale of JWH-073. JWH-073 is considered a Schedule 9 prohibited substance in Australia under the Poisons Standard (October 2015). A Schedule 9 substance is a substance which may be abused or misused, the manufacture, possession, sale or use of which should be prohibited by law except when required for medical or scientific research, or for analytical, teaching or training purposes with approval of Commonwealth and/or State or Territory Health Authorities.

### New Zealand

On 8 May 2014 the New Zealand government banned the sale of JWH-073.

### Turkey

On 7 January 2011 the Turkey government banned the sale of JWH-073.

### Germany

JWH-073 has been classified under the BtMG as Anlage II.
`,
};
